Basic Information
| LncRNA/CircRNA Name | lncRNA-D16366 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 |
| Methods | qPCR, etc. |
| Sample | HCC tissues |
| Expression Pattern | down-regulated |
| Function Description | lncRNA-D16366 was proved to be decreased in the tissues and serum among patients with HCC compared with the corresponding controls. |
| Pubmed ID | 31475695 |
| Year | 2019 |
| Title | lncRNA-D16366 Is a Potential Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma |
External Links
| Links for lncRNA-D16366 | GenBank HGNC NONCODE |
| Links for hepatocellular carcinoma | OMIM COSMIC |